Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

HISTOACRYL® Used for Embolization of Thoracoabdominal Artery Bleeding

NCT: NCT07753005 · NOT_YET_RECRUITING

NCT IDNCT07753005
StatusNOT_YET_RECRUITING
Start Date2026-09-30
Completion2028-06
SponsorAesculap AG (INDUSTRY)
First posted
Last updated

Brief Summary

This observational study will collect information from adult patients in Japan who are treated with Histoacryl® to stop bleeding from arteries in the chest or abdomen, in order to better understand how well the treatment works and how safe it is during routine medical care.

Frequently Asked Questions

What is HISTOACRYL® Used for Embolization of Thoracoabdominal Artery Bleeding?

HISTOACRYL® Used for Embolization of Thoracoabdominal Artery Bleeding is a clinical trial registered under NCT07753005. Current status: NOT_YET_RECRUITING.

What is the status of NCT07753005?

The current status of NCT07753005 (HISTOACRYL® Used for Embolization of Thoracoabdominal Artery Bleeding) is: NOT_YET_RECRUITING.

When did HISTOACRYL® Used for Embolization of Thoracoabdominal Artery Bleeding start?

HISTOACRYL® Used for Embolization of Thoracoabdominal Artery Bleeding started on 2026-09-30.

Related Devices

K151165Aesculap Dafilon Nonabsorbable Polyamide Surgical SutureAesculap, Inc. K152960ELAN 4 Motor SystemAesculap, Inc. K160393AdTecAesculap, Inc. K161853proGAV Programmable Shunt System, proGAV 2.0 Adjustable Shunt System, proSA Adjustable Shunt SystemAesculap, Inc. K162815SterilContainer S SystemAesculap, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑